Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or District of Columbia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to District of Columbia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. District of Columbia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Faysal Haroun (NPI 1598078990)

Field	Value
Entity Type	Individual
Organization	Faysal Haroun
Address	2150 Pennsylvania Ave Nw Ste 5-404
City	Washington
State	DC
ZIP	20037
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	July 14, 2010

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

This provider’s commercial footprint is effectively single‑payer at the beneficiary level: total Medicare revenue is $2.4M and there is no Medicaid billing on file, indicating Medicare accounts for essentially the entire public‑payer activity reported here. That concentration means the provider’s public revenue is highly exposed to Medicare utilization and reimbursement changes.

Revenue is extremely concentrated in a small set of drugs and administration codes: the precomputed top 3 Medicare codes by revenue account for 93.7% of this provider's total Medicare revenue. The three top contributors are J9271 ($1.5M revenue, 63.3%), J9299 ($688.3K revenue, 28.8%), and 96413 ($38.1K revenue, 1.6%), so the practice’s economics are dominated by a narrow set of oncology therapies.

The code mix is consistent with a Hematology & Oncology infusion practice that primarily bills for high‑cost immunotherapy agents rather than visit‑based E/M or routine chemotherapy administration. J9271 (pembrolizumab) and J9299 (nivolumab) together drive the lion’s share of revenue while E/M codes such as 99215 ($37.7K) and 99214 ($29.4K) and chemotherapy administration 96413 ($38.1K) represent only small portions of total Medicare revenue. This suggests the operation is organized around outpatient infusion of checkpoint inhibitors rather than office visits or high-volume traditional chemo infusions.

On competitive standing for pembrolizumab, the provider is a national high‑volume participant: J9271 has 35.2K claims, $43 avg paid/claim and ranks #60 of 1841 providers nationally (97th percentile), and is described as notably above typical national volume for this code. That ranking places the provider among the upper tier of Medicare billers nationwide for this specific immunotherapy agent.

By contrast, the provider’s nivolumab activity is less exceptional: J9299 shows 28.7K claims, $24 avg paid/claim, $688.3K revenue and ranks #86 of 505 providers nationally (83th percentile) with a characterization of typical, unremarkable volume. Routine chemotherapy administration 96413 ranks #1763 of 7514 providers (76th percentile) and is also described as typical, indicating strong drug‑focused volume but modest procedural or infusion complexity relative to national chemotherapy billing peers.

Several codes show very high claim counts paired with low average paid/claim amounts, which highlights a billing profile measured in many units rather than high per‑claim payments. Examples include J9271 (35.2K claims, $43 avg paid/claim), J9299 (28.7K claims, $24 avg paid/claim), and J1439 (23.8K claims, $1 avg paid/claim); additionally J1453 reports 8.6K claims with $0 revenue. These patterns are consistent with per‑unit reporting for injectable biologics and supportive agents and suggest operational scale in infusion throughput.

The provider has an established national presence by tenure: the NPI was enumerated 2010-07-14 (~16 years ago), indicating a long‑standing billing history. Combined with the high national rank on J9271, this tenure supports the interpretation of an established infusion practice rather than a recent entrant.

From an operational and payer‑risk perspective, the practice’s dependence on two high‑revenue immunotherapy codes creates sensitivity to utilization shifts or reimbursement policy changes affecting those agents, and the absence of Medicaid billing on file means there is no in‑state public‑payer diversification to buffer those risks. Analysts should treat this as a Medicare‑concentrated oncology infusion provider whose financial profile is tightly linked to pembrolizumab and nivolumab utilization.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	35,200	$40	$1.5M
J9299	Injection, nivolumab, 1 mg	28,680	$20	$688.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	310	$120	$38.1K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	240	$160	$37.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	280	$110	$29.4K
J1439	Injection, ferric carboxymaltose, 1 mg	23,800	$1	$23.8K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	280	$80	$22.4K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	80	$60	$5K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	20	$180	$4.4K
96375	Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the…	280	$20	$4.3K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. District of Columbia Distribution

Faysal Haroun — 6 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — District of Columbia

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	1	10	25,100	$40	$1.1M
J9299	1	10	28,680	$20	$678.3K
J2506	1	10	280	$80	$22.5K
J1439	1	10	23,800	$1	$21K
99233	478	650	90	$100	$17.6K
99214	247	1,400	90	$100	$15.3K
99215	57	660	50	$130	$12.3K
96413	1	20	60	$120	$11.4K
99213	541	1,200	50	$70	$8.5K
99223	490	610	40	$140	$8.4K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Faysal Haroun, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
North Memorial Health Care	MN	Ambulance	$0	$112.8M
Fairview Health Services	MN	General Acute Care Hospital	$0	$90.4M
Medical Faculty Associates, Inc	DC	Anesthesiology Physician	$0	$75.7M
Fairview Health Services	MN	Land Ambulance	$2.3M	$48.5M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Regions Hospital	MN	General Acute Care Hospital	$0	$44.4M
Fairview Express Care	MN	Specialist	$0	$33.1M
North Memorial Health Care	MN	General Acute Care Hospital	$0	$32.5M
Fairview Health Services	MN	General Acute Care Hospital	$0	$30M
Fairview Health Services	MN	Emergency Medicine Physician	$0	$26.6M

Nearby Providers

Other providers in the same ZIP code as Faysal Haroun, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
District Hospital Partners L P	DC	General Acute Care Hospital	$0	$136.3M
Baymark Health Services Of West Virginia, Inc.	DC	Substance Use Disorder Rehabilitation Clinic/Center	$571.6K	$6.4M
Medical Home Development Group	DC	Family Medicine Physician	$0	$6.7M
The Foundation For Contemporary Mental Health	DC	Public Health or Welfare Agency	$0	$5.4M
Dva Renal Healthcare Inc	DC	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$3.9M
Miriam's Kitchen	DC	Case Management Agency	$0	$3.1M
Rishi Sood	DC	Vascular & Interventional Radiology Physician	$2.2M	$0
Matthew Forsthoefel	DC	Radiation Oncology Physician	$1.1M	$0
Mustafa Ali	DC	Internal Medicine Physician	$135.4K	$909.4K
Jonathan Johnson	DC	Surgery Physician	$825K	$16.5K

Faysal Haroun — Billing Profile & Reimbursement Data

Sign up for Faysal Haroun — Billing Profile & Reimbursement Data policy alerts

Faysal Haroun — Billing Profile & Reimbursement Data

Sign up for Faysal Haroun — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References